Glycovax-002 is under clinical development by Glycovax Pharma and currently in Phase I for Coronavirus Disease 2019 (COVID-19).
Fenretinide is under clinical development by Laurent Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19).
Hosted on MSN20h
Today-History-Jan05
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...